Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.
Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, Fusté LC, Heinz-Peer G, Judmaier W, Laniado M, Manfredi RM, Mathieu DG, Müller D, Mortelè K, Reimer P, Reiser MF, Robinson PJ, Shamsi K, Strotzer M, Taupitz M, Tombach B, Valeri G, van Beers BE, Vogl TJ; European EOB-study group. Hammerstingl R, et al. Eur Radiol. 2008 Mar;18(3):457-67. doi: 10.1007/s00330-007-0716-9. Epub 2007 Dec 6. Eur Radiol. 2008. PMID: 18058107
Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, Laniado M, Manfredi RM, Mathieu DG, Mueller D, Reimer P, Robinson PJ, Strotzer M, Taupitz M, Vogl TJ; European EOB Study Group. Huppertz A, et al. Radiology. 2004 Jan;230(1):266-75. doi: 10.1148/radiol.2301020269. Radiology. 2004. PMID: 14695400 Clinical Trial.
Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial.
Tombach B, Bohndorf K, Brodtrager W, Claussen CD, Düber C, Galanski M, Grabbe E, Gortenuti G, Kuhn M, Gross-Fengels W, Hammerstingl R, Happel B, Heinz-Peer G, Jung G, Kittner T, Lagalla R, Lengsfeld P, Loose R, Oyen RH, Pavlica P, Pering C, Pozzi-Mucelli R, Persigehl T, Reimer P, Renken NS, Richter GM, Rummeny EJ, Schäfer F, Szczerbo-Trojanowska M, Urbanik A, Vogl TJ, Hajek P. Tombach B, et al. Eur Radiol. 2008 Nov;18(11):2610-9. doi: 10.1007/s00330-008-1054-2. Epub 2008 Jul 8. Eur Radiol. 2008. PMID: 18607594 Clinical Trial.
Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
Filippone A, Blakeborough A, Breuer J, Grazioli L, Gschwend S, Hammerstingl R, Heinz-Peer G, Kittner T, Laghi A, Leen E, Lencioni R, Lucidarme O, Remplik P, Robinson PJ, Ruehm SG, Schaefer F, Stoupis C, Tombach B, Valette PJ, Zech CJ, Huppertz A. Filippone A, et al. J Magn Reson Imaging. 2010 Feb;31(2):356-64. doi: 10.1002/jmri.22054. J Magn Reson Imaging. 2010. PMID: 20099349 Clinical Trial.
Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, Clement O, Heinz-Peer G, Stacul F, Webb JAW, Thomsen HS. van der Molen AJ, et al. Among authors: heinz peer g. Eur Radiol. 2018 Jul;28(7):2845-2855. doi: 10.1007/s00330-017-5246-5. Epub 2018 Feb 9. Eur Radiol. 2018. PMID: 29426991 Free PMC article. Review.
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines.
Stacul F, Bertolotto M, Thomsen HS, Pozzato G, Ugolini D, Bellin MF, Bongartz G, Clement O, Heinz-Peer G, van der Molen A, Reimer P, Webb JAW; ESUR Contrast Media Safety Committee. Stacul F, et al. Eur Radiol. 2018 Feb;28(2):683-691. doi: 10.1007/s00330-017-5023-5. Epub 2017 Aug 30. Eur Radiol. 2018. PMID: 28856420 Free PMC article. Review.
Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, Clement O, Heinz-Peer G, Stacul F, Webb JAW, Thomsen HS. van der Molen AJ, et al. Among authors: heinz peer g. Eur Radiol. 2018 Jul;28(7):2856-2869. doi: 10.1007/s00330-017-5247-4. Epub 2018 Feb 7. Eur Radiol. 2018. PMID: 29417249 Free PMC article. Review.
Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee Guidelines.
Roditi G, Khan N, van der Molen AJ, Bellin MF, Bertolotto M, Brismar T, Correas JM, Dekkers IA, Geenen RWF, Heinz-Peer G, Mahnken AH, Quattrocchi CC, Radbruch A, Reimer P, Romanini L, Stacul F, Thomsen HS, Clément O. Roditi G, et al. Among authors: heinz peer g. Eur Radiol. 2022 May;32(5):3056-3066. doi: 10.1007/s00330-021-08433-4. Epub 2022 Feb 17. Eur Radiol. 2022. PMID: 35175378 Free PMC article.
Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.
Thomsen HS, Morcos SK, Almén T, Bellin MF, Bertolotto M, Bongartz G, Clement O, Leander P, Heinz-Peer G, Reimer P, Stacul F, van der Molen A, Webb JA; ESUR Contrast Medium Safety Committee. Thomsen HS, et al. Eur Radiol. 2013 Feb;23(2):307-18. doi: 10.1007/s00330-012-2597-9. Epub 2012 Aug 4. Eur Radiol. 2013. PMID: 22865271 Review.
77 results